100s of titles, one news app for just $10 a month.
Latest Business news:
China's Gen Z Has the Power to Make or Break Western Brands
Young, nationalistic shoppers are derailing big bets on China
Read news from The Economist, FT, Bloomberg and more, with one subscription
Learn More
Countries agree to overhaul WHO funding model
Geneva (AFP) - The World Health Organization's member states agreed Tuesday to overhaul how they fund the UN health agency,…
Coinbase has been testing an app that allows staff to rate each other
Dot Collector was first implemented by Bridgewater Associates, a prolific hedgefund, to encourage transparency.
The impact of Indonesia's ban on palm oil exports reverberated across the globe
Amid an ongoing global food price crisis, vegetable oils are registering record-breaking highs. According to data compiled by the Food…
Argentina to ease exchange control for oil and gas companies
Buenos Aires (AFP) - Argentina on Tuesday announced an easing of foreign exchange controls for the shale oil and gas…
From analysis to good news, read the world’s best news in one place
Google urged to stop location tracking to protect privacy of abortion seekers
San Francisco (AFP) - A group of US Democratic lawmakers urged Google on Tuesday to stop collecting smartphone location data…
Stocks mostly fall after sentiment Snap-ped
New York (AFP) - Stock markets retreated Tuesday on renewed concerns over weak global growth following a profit warning from the…

Analyst Ratings for Genmab

By Benzinga Insights

Within the last quarter, Genmab (NASDAQ:GMAB) has observed the following analyst ratings:

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 0 0 3 1 0
Last 30D 0 0 1 0 0
1M Ago 0 0 1 1 0
2M Ago 0 0 0 0 0
3M Ago 0 0 1 0 0

According to 4 analyst offering 12-month price targets in the last 3 months, Genmab has an average price target of $34.25 with a high of $39.00 and a low of $30.00.

Below is a summary of how these 4 analysts rated Genmab over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock

This current average represents a 9.87% decrease from the previous average price target of $38.00.

What Are Analyst Ratings?

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

What is inkl?
The world’s most important news, from 100+ trusted global sources, in one place.
Morning Edition
Your daily
news overview

Morning Edition ensures you start your day well informed.

No paywalls, no clickbait, no ads
Enjoy beautiful reading

Content is only half the story. The world's best news experience is free from distraction: ad-free, clickbait-free, and beautifully designed.

Expert Curation
The news you need to know

Stories are ranked by proprietary algorithms based on importance and curated by real news journalists to ensure that you receive the most important stories as they break.